Advances in Biology and Therapy of Multiple Myeloma Volume 2: Translational and Clinical Research /
Despite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in...
Corporate Author: | |
---|---|
Other Authors: | , |
Format: | Electronic |
Language: | English |
Published: |
New York, NY :
Springer New York : Imprint: Springer,
2013.
|
Subjects: | |
Online Access: | View fulltext via EzAccess |
Table of Contents:
- T cell responses in myeloma
- Novel antigenic targets for immunotherapy in myeloma
- Antibody-based therapies in Multiple Myeloma
- Defining multiple myeloma as a target for DNA gene fusion vaccines
- Harnessing allogeneic immunity for anti-myeloma response
- Dendritic cell and peptide-based vaccination in myeloma
- New Proteasome inhibitors
- Newer Imids
- New agents in myeloma
- Early Combination Studies in MM
- The effect of novel antimyeloma agents on bone metabolism
- Index.